Method for identifying hook effect in homogeneous photochemiluminescence immunoassay for HBsAg

By using specific reaction combinations to identify the hook effect of HBsAg in photolass chemiluminescence homogeneous immunoassay, the problem of misleading detection results and cumbersome operation is solved, and fast and accurate quantitative HBsAg detection is achieved, reducing detection cost and time.

CN114594260BActive Publication Date: 2024-11-01THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210316595.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-03-28
Publication Date
2024-11-01
Estimated Expiration
2042-03-28

AI Technical Summary

Technical Problem

Photo-laser chemiluminescence homogeneous immunoassay technology is prone to hook effects when detecting HBsAg, resulting in low detection results of high-concentration samples, misleading clinical treatment, and existing identification methods require manual dilution to increase the cumbersome operation and detection time.

Method used

The luminescent signal value is read by adding hepatitis B surface antibodies coated on the surface of luminescent particles, the hepatitis B surface antibodies labeled with biotin and the avidin coated photosensitive particles to the suspected hook sample in sequence to perform a mixture reaction, and the luminescent signal value is determined if the signal value is greater than 4000. It is a hook sample, if it is less than 2000, it is determined as a non-hook sample, so that it can quickly identify and reduce detection costs.

Benefits of technology

Directly identify the hook effect in HBsAg detection without dilution. The recognition process takes only 1 minute to complete, which is completely automated, improves detection efficiency, ensures the accuracy of the quantitative HBsAg detection results, and reduces the dosage and detection of antibody reagents cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114594260B_ABST
    Figure CN114594260B_ABST
Patent Text Reader

Abstract

The present invention provides a method for identifying the hook effect in photoinduced chemiluminescence homogeneous immunoassay of HBsAg, the steps of which include providing a suspected hook sample, adding hepatitis B surface antibody coated on the surface of luminescent microparticles, hepatitis B surface antibody labeled with biotin, and photosensitive microparticles coated with avidin in the suspected hook sample in order for mixed reaction, and reading the luminescent signal value after the reaction, if the signal value is greater than 4000, the suspected hook sample is determined as a hook sample, and if the signal value is less than 2000, the suspected hook sample is determined as a non-hook sample. The method can directly identify the hook effect in HBsAg detection without dilution, the reaction time is short, the whole process can be completed completely by full automation, it is convenient and fast, and the clinical detection efficiency is greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of immunoassay, and in particular to a method for identifying hook effects in photoinduced chemiluminescence homogeneous immunoassay of HBsAg. Background Art

[0002] Photochemiluminescence homogeneous immunoassay technology is a new type of immunological detection technology. This technology can identify the bound phase and the unbound phase by the principle of the distance between the antigen and the antibody being shortened after binding, and can achieve homogeneous detection. The traditional immunoassay technology is to detect in a heterogeneous manner, and this process requires washing to separate the bound phase and the unbound phase. Therefore, photochemiluminescence homogeneous immunoassay technology can save the washing process. By eliminating this process, the detection speed can be accelerated, while avoiding the contamination caused by unclean washing, and the precision is better. However, not washing also brings about the problem of hook effect, that is, when the concentration of the test object is extremely high, the test result will appear as a lower value, especially for projects using the sandwich method. Among the current infectious disease detection projects, most are qualitative tests, so even if the hook effect occurs, it does not affect the normal qualitative diagnosis.

[0003] However, there is often a need for quantitative measurement of hepatitis B surface antigen (HBsAg) in clinical practice. At present, the most ideal effect of clinical hepatitis B treatment is a decrease in HBsAg concentration, which eventually becomes negative. However, when using the photochemiluminescence detection platform for detection, if a hook effect occurs, it will mislead clinical treatment. That is, the sample originally has an extremely high concentration, such as 1,000,000 ng / mL, but the test results are lower, often only 50-300 ng / mL. Although the effect of treatment is more obvious after a period of time, the photochemiluminescence detection platform cannot detect the decrease in sample concentration. This will mislead the clinical treatment plan into being ineffective, when in fact the treatment has a better effect.

[0004] The current method for identifying the hook effect is to dilute the suspected hook sample after testing it with a photochemiluminescence detection platform, and then test the diluted sample again with the photochemiluminescence detection platform. However, since not all instruments are equipped with a dilution function, manual dilution is required, which increases the complexity of clinical operations, and the test time is doubled after dilution, which greatly reduces the detection efficiency. Summary of the invention

[0005] The purpose of the present invention is to address the deficiencies of the prior art and thus provide a method for identifying the hook effect in photoinduced chemiluminescence homogeneous immunoassay of HBsAg.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is: a method for identifying the hook effect in photoinduced chemiluminescence homogeneous immunoassay of HBsAg, comprising the following steps:

[0007] Step 1: Provide a suspected hook sample;

[0008] Step 2: Add hepatitis B surface antibody coated on the surface of luminescent microparticles, hepatitis B surface antibody labeled with biotin, and photosensitive microparticles coated with avidin in order to the suspected hook sample for mixed reaction, and read the luminescent signal value after the reaction. If the signal value is greater than 4000, the suspected hook sample is determined to be a hook sample. If the signal value is less than 2000, the suspected hook sample is determined to be a non-hook sample.

[0009] The specific reasons are as follows: the present invention compares the classification of samples determined by the existing dilution method, and finds that when the sample is non-hook, its luminescent signal value is basically lower than 2000; and when the sample is a hook sample, its luminescent signal value is basically higher than 4000. If the present invention only sets a critical value for specific division, then the samples near the critical value cannot be accurately classified. Therefore, the present invention determines the suspected hook sample as a hook sample if the signal value is greater than 4000, and determines the suspected hook sample as a non-hook sample if the signal value is less than 2000, so that the samples between 2000 and 4000 have a larger buffer area and a clear boundary, and the samples between 2000 and 4000 can be further classified by the existing dilution method. That is, the present invention is particularly suitable for the rapid detection of large batches of samples, and effectively solves the problem that the normal clinical report time cannot be met due to the large number of diluted samples when testing large batches of samples.

[0010] Based on the above, in step 2, the volume ratio of the suspected hook sample, the hepatitis B surface antibody coated on the surface of the luminescent microparticle, the hepatitis B surface antibody labeled with biotin, and the avidin-coated photosensitive microparticle is 1:1:1:10.

[0011] Based on the above, the step two includes: adding 10 μL of the hepatitis B surface antibody coated on the surface of the luminescent microparticles, 10 μL of the hepatitis B surface antibody labeled with biotin, and 100 μL of the photosensitive microparticles coated with avidin in sequence to 10 μL of the suspected hook sample, and then mixing and reacting at 37°C for 1 minute, and reading the luminescent signal value after the reaction. If the signal value is greater than 4000, the suspected hook sample is determined as a hook sample; if the signal value is less than 2000, the suspected hook sample is determined as a non-hook sample.

[0012] Based on the above, step one includes: using a photoluminescence detection platform to detect the hepatitis B surface antigen sample, reading the luminescence signal value after the reaction, and obtaining the concentration result according to the existing calibration curve, and determining the hepatitis B surface antigen sample with a concentration of 0.2ng / mL to 500ng / mL as a suspected hook sample.

[0013] Specifically, step one includes: mixing 25 μL of hepatitis B surface antigen sample with 25 μL of hepatitis B surface antibody coated on the surface of luminescent particles and 25 μL of hepatitis B surface antibody labeled with biotin for 15 minutes, and then adding 175 μL of avidin-coated photosensitive particles thereto for 10 minutes. The entire reaction is carried out at 37°, and the luminescent signal value after the reaction is read, and the concentration result is obtained based on the existing calibration curve, and the hepatitis B surface antigen sample with a concentration of 0.2 ng / mL to 500 ng / mL is determined as a suspected hook sample.

[0014] Compared with the prior art, the present invention has outstanding substantive features and significant progress. Specifically, the present invention provides a method for identifying the hook effect in photoinduced chemiluminescence homogeneous immunoassay of HBsAg, which can directly identify the hook effect existing in HBsAg detection without dilution, and the identification process can be completed in only 1 minute, without manual dilution, and the reaction time is short. The entire process can be completed completely by full automation, which is convenient and fast, and greatly improves the clinical detection efficiency.

[0015] Furthermore, the present invention determines the suspected hook sample as a hook sample if the signal value is greater than 4000, and determines the suspected hook sample as a non-hook sample if the signal value is less than 2000. The reason is that the present invention compares the classification of the sample by final determination with the existing dilution method, and finds that when the sample is non-hook, its luminescent signal value is basically lower than 2000; and when the sample is a hook sample, its luminescent signal value is basically higher than 4000, so that the hook sample and the non-hook sample can have a good degree of distinction and high recognition, solve the existing hook problem, and ensure the accuracy of the clinical HBsAg quantitative detection results. And in the case of unchanged concentration, the amount of clinical samples and the volume of relatively expensive antibody reagents are reduced to only 10 microliters, there is no higher requirement for the amount of clinical samples taken, and the detection cost required is also relatively small, so as to achieve the goal of efficiently, quickly and accurately solving the hook problem of HBsAg quantitative detection at a low cost. Therefore, the present invention is particularly suitable for rapid testing of large quantities of samples, and effectively solves the problem that the normal clinical report issuance time cannot be met due to a large number of diluted samples when testing large quantities of samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 When the sample is detected by conventional dilution method and the method provided by the present invention, each symbol in the reaction mechanism refers to a substance.

[0017] Figure 2 This is the reaction mechanism of the sample when the sample is tested using the conventional dilution method. In the figure, A represents the reaction type that occurs in the non-hook sample, and B represents the reaction type that occurs in the hook sample.

[0018] Figure 3 This is the reaction mechanism when the method provided by the present invention is used to detect a sample. In the figure, A represents the reaction type that occurs in a non-hook sample, and in the figure, B represents the reaction type that occurs in a hook sample. DETAILED DESCRIPTION

[0019] The technical solution of the present invention is further described in detail below through specific implementation methods.

[0020] This embodiment provides a method for identifying the hook effect in photoinduced chemiluminescence homogeneous immunoassay of HBsAg, comprising the following steps:

[0021] Step 1: Provide a suspected hook sample;

[0022] Step 2: Add 10 μL of the hepatitis B surface antibody coated on the surface of the luminescent microparticles, 10 μL of the hepatitis B surface antibody labeled with biotin, and 100 μL of the photosensitive microparticles coated with avidin in order to the 10 μL suspected hook sample, then mix and react at 37°C for 1 minute, and read the luminescent signal value after the reaction. If the signal value is greater than 4000, the suspected hook sample is determined as a hook sample, and if the signal value is less than 2000, the suspected hook sample is determined as a non-hook sample. Samples between 2000 and 4000 can be further classified by the existing dilution method.

[0023] Specifically, in this embodiment, the automatic photochemiluminescence detector LiCA500 produced by Kemei Diagnostics Technology Co., Ltd. was used to conduct the test and read the luminescence signal value after the reaction. At the same time, by comparison, the luminescence signal values ​​measured by the automatic photochemiluminescence detectors produced by other manufacturers for the same batch of suspected hook samples were basically the same, that is, the manufacturer of the automatic photochemiluminescence detector did not affect the determination of the luminescence signal value.

[0024] Specifically, in this embodiment, step one includes: mixing 25 μL of hepatitis B surface antigen sample with 25 μL of hepatitis B surface antibody coated on the surface of luminescent particles and 25 μL of hepatitis B surface antibody labeled with biotin for 15 minutes, and then adding 175 μL of avidin-coated photosensitive particles thereto for 10 minutes. The entire reaction is carried out at 37°, and the luminescent signal value after the reaction is read. The concentration result is obtained based on the existing calibration curve, and the hepatitis B surface antigen sample with a concentration of 0.2 ng / mL to 500 ng / mL is determined as a suspected hook sample.

[0025] Specifically, Figure 1 and Figure 2 As shown in the figure, when the suspected hook sample is tested again using the conventional dilution method, the following two situations will occur:

[0026] When the suspected hook sample is actually a non-hook sample: all antigens form a double antibody sandwich mode with the reagent; when the suspected hook sample is actually a hook sample: only some antigens can form a triple complex. Although the antigen amount is very high, the detection signal value cannot be fully reflected.

[0027] More specifically, if Figure 1 and Figure 2 As shown, Figure 2 In the non-hook sample in A, almost all antigens react with the reagent to form a triple complex. Figure 2 A part of the hook sample in B forms a triple complex in the double antibody sandwich mode, but some of them form respective diplexes with reagent A and reagent B respectively, and cannot form a triple complex. The antigen in this part is equivalent to being undetectable. Therefore, the final test result is close to that of A and cannot be effectively distinguished.

[0028] Specifically, Figure 1 and Figure 3 As shown, when the method provided by the present invention is used to detect suspected hook samples, the following two situations may occur.

[0029] When the suspected hook sample is actually a non-hook sample: Since the universal solution is added at the first time of the reaction, and the affinity of biotin and avidin is much greater than the antigen-antibody binding time, and since the concentration of HBsAg is not high, reagent B will first bind to the universal solution. In this way, reagent B in free form will be enriched in large quantities on the photosensitive particles coated with avidin, which may cause two situations: 1. The diffusion ability of free antibodies is weakened, making it more difficult to collide with HBsAg; 2. Since one avidin has to bind to four biotins, it may cause steric hindrance, and the reaction lasts only 1 minute, so the signal value is very low, close to the background of the reagent.

[0030] When the suspected hook sample is actually a hook sample: Although the affinity of biotin and avidin is much greater than the antigen-antibody reaction, the antigen-antibody binding requires collision first and then consider the affinity. When the hook effect exists, the amount of hepatitis B surface antigen is extremely high, and the probability of antigen-antibody collision is extremely high at this time. The triple complex of reagent A-hepatitis B surface antigen-reagent B will be formed first. Although the reaction time is only 1 minute, due to the high antigen concentration, more triple complexes can be formed, and then combined with the universal solution. Therefore, the final triple complex is closer to the currently used detection scheme.

[0031] Right now Figure 3 The triple complex formed in Figure B is closer to the normal detection, but the triple complex formed in Figure A according to this mode is close to 0. Therefore, there will be a significant difference in the detection signal values ​​between the two, so that there is a better distinction between the hook effect.

[0032] Comparative test

[0033] In order to verify the accuracy of the method for identifying the hook effect in the photochemiluminescence homogeneous immunoassay of HBsAg provided in this embodiment, the same batch of suspected hook samples were diluted according to the traditional dilution method, and then the diluted samples were tested again using the photochemiluminescence detection platform, and the suspected hook samples were tested according to the method provided in this embodiment to determine whether the suspected hook samples were non-hook samples or hook samples. The specific test results are shown in Table 1.

[0034] Among them, in the conventional dilution method, the sample of random negative (eight infectious disease items are all negative) serum is diluted 10 times and then tested. The judgment criteria are: after diluting 10 times, the detection concentration value is greater than 500ng / mL, which is a hook sample; after diluting 10 times, the concentration value is less than the original detection concentration, which is a non-hook sample.

[0035] According to the method provided in this embodiment, the judgment standard is: if the measured signal value is greater than 4000, it is judged as a hook sample, and if the measured signal value is less than 2000, the sample is judged as a non-hook sample.

[0036] As can be seen from Table 1, the detection accuracy of the method provided in this embodiment is the same as that of the conventional dilution method. However, since this method can directly identify the hook effect in HBsAg detection without dilution, and only takes 1 minute to complete the identification process, no manual dilution is required, the reaction time is short, and the entire process can be completed completely by full automation, which is convenient and fast, greatly improving the clinical detection efficiency.

[0037] At the same time, the method has good distinction between hook samples and non-hook samples, with high recognition, which solves the existing hook problem and ensures the accuracy of clinical HBsAg quantitative detection results. In addition, the amount of clinical samples and the volume of relatively expensive antibody reagents are reduced to only 10 microliters without changing the concentration. There is no higher requirement for the amount of clinical samples collected, and the detection cost is also relatively small. Thus, the hook problem of HBsAg quantitative detection can be solved efficiently, quickly and accurately at a very low cost.

[0038] Specifically, the original detection concentration in Table 1 refers to the first detection of the hepatitis B surface antigen sample using the photoluminescence detection platform, reading the luminescence signal value after the reaction, and obtaining the concentration value based on the existing calibration curve.

[0039] The serum dilution 10 times detection concentration means that after the hepatitis B surface antigen sample is diluted 10 times, the hepatitis B surface antigen sample is tested again using the photochemiluminescence detection platform, the luminescent signal value after the reaction is read, and the concentration value is obtained based on the existing calibration curve.

[0040] The signal value of the method of the present invention refers to the luminescent signal value obtained by examining the hepatitis B surface antigen sample using the method provided by the present invention.

[0041] Table 1. Comparison of detection results of hook samples identified by the method of the present invention and the conventional dilution method

[0042]

[0043]

[0044]

[0045]

[0046]

[0047]

[0048]

[0049]

[0050]

[0051]

[0052]

[0053] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, ordinary technicians in the field should understand that the specific implementation methods of the present invention can still be modified or some technical features can be replaced by equivalents without departing from the spirit of the technical solution of the present invention, which should be included in the scope of the technical solution for protection of the present invention.

Claims

1. A method for identifying the hook effect in photochemiluminescence homogeneous immunoassay of HBsAg, comprising the following steps: Step 1: Mix 25µL of HBsAg sample with 25µL of HBsAg coated on the surface of luminescent microparticles and 25µL of HBsAg labeled with biotin for 15 minutes, then add 175µL of avidin-coated photosensitive microparticles for 10 minutes. The whole reaction is carried out at 37°C and the photoluminescence detection platform LiCA is used. ® 500 Read the luminescent signal value after the reaction, and obtain the concentration result according to the existing calibration curve, and determine the hepatitis B surface antigen samples with a concentration of 0.2ng / mL to 500ng / mL as suspected hook samples; Step 2: Add 10µL of the HBsAg coated on the surface of the luminescent microparticles, 10µL of the HBsAg labeled with biotin, and 100µL of the photosensitive microparticles coated with avidin in order to the 10µL suspected hook sample, and then mix and react at 37°C for 1 minute, and use the photoluminescence detection platform LiCA ® 500 Read the luminescent signal value after the reaction. If the signal value is greater than 4000, the suspected hook sample is determined as a hook sample. If the signal value is less than 2000, the suspected hook sample is determined as a non-hook sample.